MX2020003681A - Metodo para preparar microparticulas por tecnica de doble emulsion. - Google Patents

Metodo para preparar microparticulas por tecnica de doble emulsion.

Info

Publication number
MX2020003681A
MX2020003681A MX2020003681A MX2020003681A MX2020003681A MX 2020003681 A MX2020003681 A MX 2020003681A MX 2020003681 A MX2020003681 A MX 2020003681A MX 2020003681 A MX2020003681 A MX 2020003681A MX 2020003681 A MX2020003681 A MX 2020003681A
Authority
MX
Mexico
Prior art keywords
phase
preparing
double emulsion
microparticles
preparing microparticles
Prior art date
Application number
MX2020003681A
Other languages
English (en)
Inventor
Robertus Franciscus Duwel
Emilie Janine Marie Blazejewski
Original Assignee
Nanomi B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanomi B V filed Critical Nanomi B V
Publication of MX2020003681A publication Critical patent/MX2020003681A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1694Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/23Calcitonins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/31Somatostatins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5031Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • A61K38/09Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Colloid Chemistry (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)

Abstract

Se proporcionan metodos para preparar microparticulas usando una tecnica de doble emulsion que combina una membrana y un micro tamiz. En particular, la presente invencion se refiere a un metodo para preparar microparticulas que comprende: preparar una primera fase que comprende un agente activo; preparar una segunda fase que comprende un vehiculo y un disolvente; pasar la primera fase y la segunda fase a traves de una membrana para formar una emulsion primaria; pasar la emulsion primaria a traves de un micro tamiz en una fase continua para formar una emulsion secundaria; y eliminar el disolvente para formar las microparticulas.
MX2020003681A 2017-09-26 2018-09-26 Metodo para preparar microparticulas por tecnica de doble emulsion. MX2020003681A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL2019632 2017-09-26
PCT/NL2018/050636 WO2019066649A1 (en) 2017-09-26 2018-09-26 PROCESS FOR THE PREPARATION OF MICROPARTICLES BY A DOUBLE EMULSION TECHNIQUE

Publications (1)

Publication Number Publication Date
MX2020003681A true MX2020003681A (es) 2020-08-03

Family

ID=60628132

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020003681A MX2020003681A (es) 2017-09-26 2018-09-26 Metodo para preparar microparticulas por tecnica de doble emulsion.

Country Status (14)

Country Link
US (1) US11052046B2 (es)
EP (1) EP3687503A1 (es)
JP (1) JP2020535224A (es)
CN (1) CN111315365A (es)
AU (2) AU2018341389A1 (es)
BR (1) BR112020006136A2 (es)
CA (1) CA3077011A1 (es)
CL (1) CL2020000793A1 (es)
CO (1) CO2020004360A2 (es)
IL (1) IL273560B (es)
JO (1) JOP20200068B1 (es)
MX (1) MX2020003681A (es)
SA (1) SA520411598B1 (es)
WO (1) WO2019066649A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12297148B2 (en) 2021-11-02 2025-05-13 Saudi Arabian Oil Company Self-repairing cement including microcapsule-in-microcapsule material and designed swellable rubber and methods for fabricating same

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389330A (en) 1980-10-06 1983-06-21 Stolle Research And Development Corporation Microencapsulation process
PH19942A (en) 1980-11-18 1986-08-14 Sintex Inc Microencapsulation of water soluble polypeptides
JPS60100516A (ja) 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
CH660302A5 (fr) 1984-10-17 1987-04-15 Debiopharm Sa Procede de micro-encapsulation en phase heterogene de substances medicamenteuses hydrosolubles.
GB2209937B (en) 1987-09-21 1991-07-03 Depiopharm S A Water insoluble polypeptides
US5439688A (en) 1989-07-28 1995-08-08 Debio Recherche Pharmaceutique S.A. Process for preparing a pharmaceutical composition
CH679207A5 (es) 1989-07-28 1992-01-15 Debiopharm Sa
US5225205A (en) 1989-07-28 1993-07-06 Debiopharm S.A. Pharmaceutical composition in the form of microparticles
EP0546174B1 (en) * 1991-06-29 1997-10-29 Miyazaki-Ken Monodisperse single and double emulsions and production thereof
CH683149A5 (fr) 1991-07-22 1994-01-31 Debio Rech Pharma Sa Procédé pour la préparation de microsphères en matériau polymère biodégradable.
JPH0558882A (ja) * 1991-09-04 1993-03-09 Yoshiaki Kawashima ナノカプセルの製造法
CH688269A5 (fr) 1992-08-21 1997-07-15 Debio Rech Pharma Sa Broyeur ultra-centrifuge et sa mise en oeuvre pour le broyage cryogénique de matériau thermosensible.
US5945126A (en) 1997-02-13 1999-08-31 Oakwood Laboratories L.L.C. Continuous microsphere process
NL1026261C2 (nl) 2004-05-25 2005-11-28 Nanomi B V Sproei inrichting met een nozzleplaat voorzien van structuren ter bevordering van self-breakup, een nozzleplaat, alsmede werkwijzen ter vervaardiging en toepassing van een dergelijke nozzleplaat.
EP1853228A4 (en) * 2005-03-01 2012-07-18 Sun Pharma Advanced Res Co Ltd METHOD FOR THE PRODUCTION OF MICROBALLS OR MICRO CAPSULES
JP4580801B2 (ja) * 2005-03-29 2010-11-17 株式会社東芝 複合型微粒子の製造方法及び複合型微粒子の製造装置
NO347209B1 (no) * 2006-12-18 2023-07-03 Takeda Pharmaceutical Sammensetning med forlenget frigjøring og fremgangsmåte for å produsere det samme
EP2334288B1 (en) * 2008-09-18 2021-05-19 Evonik Corporation Microencapsulation process with solvent and salt
WO2010085607A1 (en) * 2009-01-23 2010-07-29 Surmodics Pharmaceuticals, Inc. Continuous double emulsion process for making microparticles
WO2011001780A1 (ja) * 2009-07-02 2011-01-06 コニカミノルタホールディングス株式会社 特定分散剤を含有する外水相を利用する二段階乳化法によるリポソームの製造方法、ならびに当該リポソームの製造方法を用いるリポソーム分散液またはその乾燥粉末の製造方法およびそれにより製造されるリポソーム分散液またはその乾燥粉末
WO2011087689A2 (en) 2009-12-22 2011-07-21 Surmodics Pharmaceuticals,Inc. Emulsion-based process for preparing microparticles and workhead assembly for use with same
CN102892406B (zh) * 2010-01-19 2015-04-08 波利皮得有限公司 缓释核酸基质组合物
RU2617057C2 (ru) * 2010-03-26 2017-04-19 Евоник Корпорейшн Эмульсии для микрокапсулирования, содержащие биоразлагаемые поверхностно-активные блок-сополимеры в качестве стабилизаторов
KR101558083B1 (ko) * 2014-04-07 2015-10-07 에스케이케미칼주식회사 약물함유 고분자미립구 제조방법

Also Published As

Publication number Publication date
JOP20200068A1 (ar) 2020-04-27
CO2020004360A2 (es) 2020-04-24
AU2018341389A1 (en) 2020-04-23
CN111315365A (zh) 2020-06-19
EP3687503A1 (en) 2020-08-05
IL273560A (en) 2020-05-31
WO2019066649A1 (en) 2019-04-04
RU2020113100A3 (es) 2021-11-25
SA520411598B1 (ar) 2022-11-30
RU2020113100A (ru) 2021-10-08
CL2020000793A1 (es) 2021-01-04
AU2024216428A1 (en) 2024-09-19
JOP20200068B1 (ar) 2024-04-18
WO2019066649A8 (en) 2019-05-31
BR112020006136A2 (pt) 2020-10-06
US20200230061A1 (en) 2020-07-23
CA3077011A1 (en) 2019-04-04
US11052046B2 (en) 2021-07-06
IL273560B (en) 2022-06-01
JP2020535224A (ja) 2020-12-03

Similar Documents

Publication Publication Date Title
MX2018015853A (es) Anticuerpos multiespecificos frente a los grupos de diferenciacion 40 y 137 (cd40 y cd137).
CL2017000824A1 (es) Moduladores de regulador de conducta de transmembranas de fibrosis cística
MX385749B (es) Composiciones que comprenden una caseína y métodos para producir las mismas.
CL2018000194A1 (es) Compuestos de piridina
MX2017008819A (es) Anticuerpos anti-cd47 y usos de los mismos.
PE20150646A1 (es) Metodos de tratamiento de una tauopatia
MX393359B (es) Método para proporcionar beneficios para el cuidado bucal
MX2016006356A (es) Metodos de tratamiento de una tauopatia.
ECSP18030284A (es) Moduladores del receptor x farnesoide
LT3750915T (lt) Naujas bispecifinis formatas, tinkamas naudoti didelio našumo atrankoje
AR089448A1 (es) Metodo para expandir el diametro de un envase metalico
PE20150972A1 (es) Soluciones de extraccion y recuperacion de soluto de extraccion para procesos de membrana impulsada osmoticamente
MX2018003357A (es) Proceso de compuesto antifungico.
HUE054788T2 (hu) Lyukasztótüskék, hozzátartozó perselyek és eljárások perselyek kialakítására felhasználva lyukasztótüskéket
CL2017002427A1 (es) Producción de ácido ribonucleico libre de células.
AR094120A1 (es) Polimero reversiblemente coagulable y redispersable que incluye al menos un monomero que incluye un grupo funcional anfifilo intercambiable y metodos para su utilizacion
CO2017003955A2 (es) Compuestos de 1-alquil-6-oxo-1,6-dihidropiridin-3-ilo y usos de los mismos
BR112014025509A2 (pt) formulação e composição de tensoativo, método para preparar uma formulação de tensoativo, e, processo para recuperar fluidos fósseis.
CO2017007316A2 (es) Formulación farmacéutica
PT3528787T (pt) Formulações farmacêuticas e métodos para produzir as mesmas
CR20150299A (es) Dispersión sólida de un modulador selectivo de los receptores de progesterona
BR112015028733A2 (pt) membrana, e método para fabricar uma membrana.
DK3373996T3 (da) Fremgangsmåde til frembringelse, anvendelse og administration af aktiverede stamceller
PE20141234A1 (es) Prensa de filtro contiguo y metodos de fabricacion de la misma
BR112013033169A2 (pt) composição que compreende um primeiro extrato de cebola (a) e lipossomas, método para a preparação de uma composição.